Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients

Arthritis and Rheumatism

Volumn 62, Issue 6, 2010, Pages 1718-1722

  Perna, Michelle ^a   Roman, Mary J ^a   Alpert, Deborah R ^a   Crow, Mary K ^a   Lockshin, Michael D ^a   Sammaritano, Lisa ^a   Devereux, Richard B ^a   Cooke, John P ^b   Salmon, Jane E ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE; RIBONUCLEOPROTEIN ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ADULT; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIAL ARTERY; SYSTEMIC LUPUS ERYTHEMATOSUS; TONOMETRY;

ADULT; AGING; ARGININE; CAROTID ARTERIES; FEMALE; HOMOCYSTEINE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VASCULAR DISEASES;

EID: 77952923345     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27392     Document Type: Article

References (25)

1. Roman MJ, Salmon JE. Cardiovascular manifestations of rheumatologic diseases. Circulation 2007;116:2346-2355
2. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-2406
3. Roman MJ, Crow MK, Lockshin MD, Devereux RB, Paget SA, Sammaritano L, et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2007:56:3412-3419
4. Thompson T, Sutton-Tyrrell K, Wildman RP, Fitzgerald SG, Shook B, Tracy RP, et al. Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 2008:58:835-842
5. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113:657-663
6. Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005;46:194-199
7. Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med 2009;60:39-54.
8. Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O, et al. Endothelial dysfunction induced by hyperhomocysteinemia: role of asymmetric dimethylarginine. Circulation 2003;108:933-938
9. Dayal S, Lentz SR. ADMA and hyperhomocysteinemia. Vasc Med 2005;10 Suppl 1:S27-33.
10. Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2008;31:747-752
11. Wilson Tang WH, Tong W, Shrestha K, Wang Z, Levison BS, Delfraino B, et al. Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur Heart J 2008:29:2506-2513
12. Kianai AN, Mahoney JA, Petri M. Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus. J Rheumatol 2007;34:1502-1505
13. Bultink EM, Teerlink T, Heijst JA, Dijkmans BA, Voskuyl AE. Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus. Ann Rheum Dis 2005;64:1362-1365
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-640
16. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-369
17. Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 2004;42:1377-1383
18. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004;50:151-159
19. Ruan L, Chen W, Srinivasan SR, Xu J, Sun M, Toprak A, et al. Relation of plasma homocysteine to arterial stiffness in black and white young adults (from the Bogalusa Heart Study). Am J Cardiol 2009;103:985-988
20. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A 1994;91:6369-6373
21. Samouillan V, Lamy E, Dandurand J, Foucault-Bertaud A, Chareyre C, Lacabanne C, et al. Changes in the physical structure and chain dynamics of elastin network in homocysteine-cultured arteries. J Biomed Mater Res A 2009. E-pub ahead of print.
22. Denny MF, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, et al. Interferon-α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007:110: 2907-2915
23. Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, Wieczorek-Surdacka E, et al. Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2007;56:809-819
24. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005;52:1491-1503
25. Von Feldt JM, Scalzi LV, Cucchiara AJ, Morthala S, Kealey C, Flagg SD, et al. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum 2006;54: 2220-2227